Profile Name
Profile desiganation
Profile Content
SanoMSC is an allogeneic mesenchymal bone marrow cell therapy candidate being developed for ischemic stroke with persistent neurologic impairment. The program is based on mesenchymal stromal/stem cell technology, clinical-stage regulatory materials, and manufacturing-readiness planning for scalable biologic development.
The SanoMSC platform is positioned around regenerative medicine, cell-based biologic development, immunomodulatory and trophic repair mechanisms, clinical manufacturing controls, and late-stage clinical development planning.